Trending News

FDA clears J&J and Grifols' blood-stopping protein

Johnson & Johnson’s Ethicon unit has received a 510(k) clearance from the FDA for its Vistaseal appl
Read More

Bio-Techne nets FDA breakthrough ticket in prostat

Bio-Techne’s urine test, designed to track down the exosomes and genomic markers released from prost
Read More

AbbVie and J&J claim new Imbruvica okay in US

The green light from the US regulator is for a regimen based on BTK inhibitor Imbruvica (ibrutinib)
Read More

Takeda's Phase III Dengue Vaccine Results Bring Th

Takeda Pharmaceutical announced that its vaccine for dengue fever hit its primary efficacy endpoint
Read More

Celgene Strikes Deal Worth Nearly $1 Billion for B

Celgene has struck another collaborative deal, even as the large pharmaceutical company is in the pr
Read More

Gates Foundation, Gilead and Others Drop $55 Milli

Lyndra Therapeutics, based in Watertown, Mass., announced the closing of a Series B financing round
Read More

Is Biogen’s Aducanumab for Alzheimer’s the Holy Gr

Whenever a drug fails an Alzheimer’s clinical trial, analysts, investors and industry watchers immed
Read More


;